BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1005913)

  • 1. In vitro alteration of the subcellular distribution of 3H-reserpine in the rat forebrain by delta 9-tetrahydrocannabinol.
    Johnson KM; Dewey WL; Ho BT
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):655-71. PubMed ID: 1005913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of rat brain opioid receptors by cannabinoids.
    Vaysse PJ; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of theophylline on binding of delta-9-tetrahydrocannabinol with mammalian neuronal and non-neuronal membranes.
    Ghosh SK; Poddar MK
    Indian J Exp Biol; 1993 Feb; 31(2):130-5. PubMed ID: 8388853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of delta9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synaptosomes.
    Bloom AS
    J Pharmacol Exp Ther; 1982 Apr; 221(1):97-103. PubMed ID: 6278139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An attempt to correlate the development of tolerance to delta-9-tetrahydrocannabinol and d-amphetamine with their subcellular distribution in rat brain.
    Magour S; Coper H; Fähndrich C
    Pol J Pharmacol Pharm; 1976; 28(6):589-92. PubMed ID: 1012982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs.
    Martin BR; Dewey WL; Harris LS; Beckner JS
    J Pharmacol Exp Ther; 1976 Jan; 196(1):128-44. PubMed ID: 1246007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
    Reichman M; Nen W; Hokin LE
    Mol Pharmacol; 1988 Dec; 34(6):823-8. PubMed ID: 2849049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
    Lindamood C; Colasanti BK
    J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH.
    Thomas BF; Wei X; Martin BR
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1383-90. PubMed ID: 1335065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
    Poddar MK; Dewey WL
    J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of delta9-tetrahydrocannabinol on the conversion of [3H]trypotphan to 5-[3H] hydroxytryptamine in the mouse brain.
    Johnson KM; Dewey WL
    J Pharmacol Exp Ther; 1978 Oct; 207(1):140-50. PubMed ID: 702335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
    Tripathi HL; Vocci FJ; Brase DA; Dewey WL
    Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta-9-Tetrahydrocannabinol: effect on mitochondrial swelling of different tissues of rat.
    Banerji A; Poddar MK; Ghosh JJ
    Methods Find Exp Clin Pharmacol; 1985 Jul; 7(7):351-6. PubMed ID: 2997559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
    Hillard CJ; Harris RA; Bloom AS
    J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic disposition of delta 8-tetrahydrocannabinol and its active metabolites, 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol, in mice.
    Watanabe K; Yamamoto I; Oguri K; Yoshimura H
    Drug Metab Dispos; 1981; 9(3):261-4. PubMed ID: 6113937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between impulse-flow and delta 9-tetrahydrocannabinol within the septal-hippocampal cholinergic pathway of rat brain.
    Lindamood C; Colasanti BK
    J Pharmacol Exp Ther; 1981 Nov; 219(2):580-4. PubMed ID: 6270316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids inhibit the respiration of human sperm.
    Badawy ZS; Chohan KR; Whyte DA; Penefsky HS; Brown OM; Souid AK
    Fertil Steril; 2009 Jun; 91(6):2471-6. PubMed ID: 18565513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta-9-tetrahydrocannabinol and theophylline: in vitro interaction with bovine serum albumin.
    Ghosh SK; Poddar MK
    Indian J Biochem Biophys; 1993 Feb; 30(1):21-5. PubMed ID: 8389726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Testing the pharmacological activity of some synthetic cannabinoids in mice (author's transl)].
    Ganz AJ; Waser PG
    Arzneimittelforschung; 1980; 30(3):471-7. PubMed ID: 7387758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.